PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy

[1] Siegel RL(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29

[2] Miller KD(2015)Screening: diagnostic dilemma Nature 528 S120-122

[3] Jemal A(2012)Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme BJU Int 110 1648-1652

[4] Sohn E(2014)Overdiagnosis and overtreatment of prostate cancer Eur Urol 65 1046-1055

[5] Boniol M(2011)A decade of exploring the cancer epigenome—biological and translational implications Nat Rev Cancer 11 726-734

[6] Boyle P(2012)Functions of DNA methylation: islands, start sites, gene bodies and beyond Nat Rev Genet 13 484-492

[7] Autier P(2013)Epigenetic reprogramming in cancer Science 339 1567-1570

[8] Ruffion A(2014)Nucleic acid-based tissue biomarkers of urologic malignancies Crit Rev Clin Lab Sci 51 173-199

[9] Perrin P(2015)Epigenetic biomarkers in the blood of patients with urological malignancies Expert Rev Mol Diagn 15 505-516

[10] Loeb S(2014)Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine PLoS One 9 e93933-104

[1] Siegel RL(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29

[2] Miller KD(2015)Screening: diagnostic dilemma Nature 528 S120-122

[3] Jemal A(2012)Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme BJU Int 110 1648-1652

[4] Sohn E(2014)Overdiagnosis and overtreatment of prostate cancer Eur Urol 65 1046-1055

[5] Boniol M(2011)A decade of exploring the cancer epigenome—biological and translational implications Nat Rev Cancer 11 726-734

[6] Boyle P(2012)Functions of DNA methylation: islands, start sites, gene bodies and beyond Nat Rev Genet 13 484-492

[7] Autier P(2013)Epigenetic reprogramming in cancer Science 339 1567-1570

[8] Ruffion A(2014)Nucleic acid-based tissue biomarkers of urologic malignancies Crit Rev Clin Lab Sci 51 173-199

[9] Perrin P(2015)Epigenetic biomarkers in the blood of patients with urological malignancies Expert Rev Mol Diagn 15 505-516

[10] Loeb S(2014)Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine PLoS One 9 e93933-104